Answers are grounded in this paper and cite their sources.
Demonstrates potent neuronal nitric oxide synthase inhibition by 6-phenyl-2-aminopyridines in rat models, indicating therapeutic potential for central nervous system disorders.
The synthesis and structure-activity relationships of a series of 6-phenyl-2-aminopyridines that potently and selectively inhibit the neuronal isoform of nitric oxide synthase (nNOS) are described. Compound 14bi from this series exhibits potent in vivo activity in harmaline-induced cGMP formation in rat cerebellum, a functional model of nNOS inhibition, and in the PCP-induced hypermotility model in the rat. These results suggest that 14bi may be a useful reagent for evaluating potential therapeutic applications of nNOS inhibitors in the central nervous system.
No takes yet. Share an insight, caveat, or question.
Lowe et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: